Your browser doesn't support javascript.
loading
Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.
Ganghammer, Sylvia; Gutjahr, Julia; Hutterer, Evelyn; Krenn, Peter W; Pucher, Susanne; Zelle-Rieser, Claudia; Jöhrer, Karin; Wijtmans, Maikel; Leurs, Rob; Smit, Martine J; Gattei, Valter; Greil, Richard; Hartmann, Tanja N.
Afiliação
  • Ganghammer S; Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria Salzburg Cancer Research Institute, Austria.
  • Gutjahr J; Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria Salzburg Cancer Research Institute, Austria.
  • Hutterer E; Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria Salzburg Cancer Research Institute, Austria.
  • Krenn PW; Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria Salzburg Cancer Research Institute, Austria.
  • Pucher S; Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria Salzburg Cancer Research Institute, Austria.
  • Zelle-Rieser C; Tyrolean Cancer Research Institute, Innsbruck, Austria.
  • Jöhrer K; Tyrolean Cancer Research Institute, Innsbruck, Austria.
  • Wijtmans M; Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division Medicinal Chemistry, VU University Amsterdam, the Netherlands.
  • Leurs R; Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division Medicinal Chemistry, VU University Amsterdam, the Netherlands.
  • Smit MJ; Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division Medicinal Chemistry, VU University Amsterdam, the Netherlands.
  • Gattei V; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Aviano, Italy.
  • Greil R; Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria Salzburg Cancer Research Institute, Austria.
  • Hartmann TN; Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria Salzburg Cancer Research Institute, Austria t.hartmann@salk.at.
Haematologica ; 101(3): e99-102, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26589908
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Leucemia Linfocítica Crônica de Células B / Regulação Leucêmica da Expressão Gênica / Receptores CXCR4 / Receptor Cross-Talk / Receptores CXCR3 Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Leucemia Linfocítica Crônica de Células B / Regulação Leucêmica da Expressão Gênica / Receptores CXCR4 / Receptor Cross-Talk / Receptores CXCR3 Idioma: En Ano de publicação: 2016 Tipo de documento: Article